细胞外囊泡:在急性心肌梗塞中分子信使和新的治疗点
Hao Wu1, Jinyi Xue1, Qiuyu Liu2
1Affiliated Traditional Chinese Medicine Hospital, Southwest Medical University, Luzhou, China.
Frontiers in immunology
|July 11, 2025
概括
细胞外囊泡 (EVs) 在急性心肌梗塞 (AMI) 中起着双重作用,既可以恶化心脏损伤,也可以修复心脏损伤. 了解这些复杂的功能是开发心血管疾病新诊断和治疗策略的关键.
科学领域:
- 心血管生物学 心血管生物学
- 细胞生物学 细胞生物学
- 生物医学科学 生物医学科学
背景情况:
- 细胞外囊泡 (EVs) 是细胞分泌的含有生物分子的纳米粒子.
- EVs与急性心肌梗塞 (AMI) 的病理生理学有关.
- 电动汽车在AMI中表现出有害和治疗效应.
研究的目的:
- 提供对EV生物发生和释放机制的全面概述.
- 阐明电动汽车在AMI中的双重监管作用.
- 探索电动汽车作为诊断生物标志物和治疗交付工具的潜力.
主要方法:
- 在AMI中对EV生物发生和功能的文献综述.
- 对心肌损伤中EVs复杂相互作用的分析.
- 探索临床翻译和精准医学应用.
主要成果:
- EVs通过亡,炎症和血管新生障碍促进AMI的进展.
- EVs通过新血管,减少细胞死亡和抑制纤维化促进心脏修复.
- 电动车具有作为诊断和治疗工具的巨大潜力.
结论:
- 在心肌损伤中,EVs具有多方面的作用,它们既具有有害作用,又具有治疗作用.
- 对EV的进一步研究对于推进心血管疾病的诊断和治疗策略至关重要.
- 阐明EV功能将支持临床翻译和心脏病学中的精准医学.
相关概念视频
Overview of Exosomes
2.9K
Exosomes are stable, lipid bilayer-enclosed vesicles capable of crossing biological barriers. They can carry a wide range of molecules required for intercellular communication. Once exosomes are released from the cell where they originated, they enter a recipient cell through various pathways such as fusion, receptor-mediated endocytosis, macropinocytosis, and phagocytosis.
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
2.9K
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
349
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
349
Myocarditis III: Medical Management
17
Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
17
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
49
The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
49


